| Product NDC: | 55390-357 |
| Proprietary Name: | CAFCIT |
| Non Proprietary Name: | caffeine citrate |
| Active Ingredient(s): | 20 mg/mL & nbsp; caffeine citrate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-357 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020793 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081104 |
| Package NDC: | 55390-357-03 |
| Package Description: | 1 VIAL in 1 BOX (55390-357-03) > 3 mL in 1 VIAL |
| NDC Code | 55390-357-03 |
| Proprietary Name | CAFCIT |
| Package Description | 1 VIAL in 1 BOX (55390-357-03) > 3 mL in 1 VIAL |
| Product NDC | 55390-357 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | caffeine citrate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20081104 |
| Marketing Category Name | NDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | CAFFEINE CITRATE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |